WH To Collaborate With Antibody Developers To Target COVID-19 Mutations

By Kelly Lienhard / January 27, 2021 at 8:03 PM

The U.S. government will collaborate with monoclonal antibody developers to target the potentially serious impacts a new strain of COVID-19 found in South Africa poses to the therapy’s efficacy, the White House COVID-19 Response Team announced Wednesday (Jan. 27).


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.